This Event is licensed under the Creative Commons BY-SA license. This license allows reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. If you remix, adapt, or build upon the material, you must license the modified material under identical terms.
Event: 1739
Key Event Title
Binding to ACE2
Short name
Biological Context
Level of Biological Organization |
---|
Molecular |
Cell term
Cell term |
---|
cell |
Organ term
Organ term |
---|
organ |
Key Event Components
Process | Object | Action |
---|---|---|
receptor binding | angiotensin-converting enzyme 2 | occurrence |
Key Event Overview
AOPs Including This Key Event
AOP Name | Role of event in AOP | Point of Contact | Author Status | OECD Status |
---|---|---|---|---|
SARS-CoV-2 leads to acute respiratory distress | MolecularInitiatingEvent | Young Jun Kim (send email) | Open for comment. Do not cite | Under Development |
Sars-CoV-2 causes encephalitis | MolecularInitiatingEvent | Anna Price (send email) | Under development: Not open for comment. Do not cite | Under Development |
S glycoprotein, taste impairment | MolecularInitiatingEvent | Young Jun Kim (send email) | Under development: Not open for comment. Do not cite | Under Development |
Viral spike protein interaction with ACE2 leads to microvascular dysfunction | MolecularInitiatingEvent | Julija Filipovska (send email) | Under Development: Contributions and Comments Welcome | |
SARS-CoV-2 causes anosmia | MolecularInitiatingEvent | Sandra Coecke (send email) | Under development: Not open for comment. Do not cite | Under Development |
Sars-CoV-2 causes stroke | MolecularInitiatingEvent | Magda Sachana (send email) | Under development: Not open for comment. Do not cite | Under Development |
SARS-CoV2 to hyperinflammation | MolecularInitiatingEvent | Hasmik Yepiskoposyan (send email) | Under development: Not open for comment. Do not cite | |
SARS-CoV2 to pyroptosis | MolecularInitiatingEvent | Hasmik Yepiskoposyan (send email) | Under development: Not open for comment. Do not cite | |
Pericytes possess a key role in the heart injury by COVID-19. | MolecularInitiatingEvent | Evangelos-Panagiotis Daskalopoulos (send email) | Under development: Not open for comment. Do not cite | |
Downregulation of ACE2 causes multi-factorial heart injury and heart failure. | MolecularInitiatingEvent | Evangelos-Panagiotis Daskalopoulos (send email) | Under development: Not open for comment. Do not cite | |
SARS-CoV-2 leads to intestinal barrier disruption | MolecularInitiatingEvent | Laure-Alix Clerbaux (send email) | Under development: Not open for comment. Do not cite | Under Development |
ACE2 dysregulation leads to gut dysbiosis | MolecularInitiatingEvent | Laure-Alix Clerbaux (send email) | Under development: Not open for comment. Do not cite | Under Development |
SARS-CoV-2 leads to infection proliferation | MolecularInitiatingEvent | Sally Mayasich (send email) | Under development: Not open for comment. Do not cite | Under Development |
SARS-CoV2 to thrombosis and DIC | MolecularInitiatingEvent | Shihori Tanabe (send email) | Under development: Not open for comment. Do not cite | Under Development |
Cytopathic SARS-CoV-2 leads to hyperinflammation | MolecularInitiatingEvent | Laure-Alix Clerbaux (send email) | Under development: Not open for comment. Do not cite |
Taxonomic Applicability
Life Stages
Life stage | Evidence |
---|---|
Adult, reproductively mature | High |
During development and at adulthood | High |
Sex Applicability
Term | Evidence |
---|---|
Mixed | High |
Key Event Description
Angiotensin-converting enzyme 2 (ACE2) is an enzyme that can be found either attached to the membrane of the cells (mACE2) in many tissues and in a soluble form form (sACE2).
A table on ACE2 expression levels according to tissues (Kim et al.)
|
Sample size |
ACE2 mean expression |
Standard deviation of expression |
Intestine |
51 |
9.50 |
1.183 |
Kidney |
129 |
9.20 |
2.410 |
Stomach |
35 |
8.25 |
3.715 |
Bile duct |
9 |
7.23 |
1.163 |
Liver |
50 |
6.86 |
1.351 |
Oral cavity |
32 |
6.23 |
1.271 |
Lung |
110 |
5.83 |
0.710 |
Thyroid |
59 |
5.65 |
0.646 |
Esophagus |
11 |
5.31 |
1.552 |
Bladder |
19 |
5.10 |
1.809 |
Breast |
113 |
4.61 |
0.961 |
Uterus |
25 |
4.37 |
1.125 |
Protaste |
52 |
4.35 |
1.905 |
ACE2 receptors in the brain (endothelial, neuronal and glial cells):
The highest ACE2 expression level in the brain was found in the pons and medulla oblongata in the human brainstem, containing the medullary respiratory centers (Lukiw et al., 2020). High ACE2 receptor expression was also found in the amygdala, cerebral cortex and in the regions involved in cardiovascular function and central regulation of blood pressure including the sub-fornical organ, nucleus of the tractus solitarius, paraventricular nucleus, and rostral ventrolateral medulla (Gowrisankar and Clark 2016; Xia and Lazartigues 2010). The neurons and glial cells, like astrocytes and microglia also express ACE-2.
In the brain, ACE2 is expressed in endothelium and vascular smooth muscle cells (Hamming et al., 2004), as well as in neurons and glia (Gallagher et al., 2006; Matsushita et al., 2010; Gowrisankar and Clark, 2016; Xu et al., 2017; de Morais et al., 2018) (from Murta et al., 2020). Astrocytes are the main source of angiotensinogen and express ATR1 and MasR; neurons express ATR1, ACE2, and MasR, and microglia respond to ATR1 activation (Shi et al., 2014; de Morais et al., 2018).
ACE2 receptors in the intestines
The highest levels of ACE2 are found at the luminal surface of the enterocytes, the differentiated epithelial cells in the small intestine, lower levels in the crypt cells and in the colon (Liang et al, 2020; Hashimoto et al., 2012, Fairweather et al. 2012; Kowalczuk et al. 2008).
How It Is Measured or Detected
In vitro methods supporting interaction between ACE2 and SARS-CoV-2 spike protein
Several reports using surface plasmon resonance (SPR) or biolayer interferometry binding (BLI) approaches. to study the interaction between recombinant ACE2 and S proteins have determined a dissociation constant (Kd) for SARS-CoV S and SARS-CoV-2 S as follow,
Reference |
ACE2 protein |
SARS-CoV S |
SARS-CoV2 S |
Method |
Measured Kd |
1–615 aa |
306–577 aa |
|
SPR |
325.8 nM |
|
|
1–1208 aa |
14.7 nM |
|||
19–615 aa |
306–527 aa |
|
SPR |
408.7 nM |
|
|
319–541 aa |
133.3 nM |
|||
19–615 aa |
306–527 aa |
|
SPR |
31.6 nM |
|
|
319–541 aa |
4.7 nM |
|||
1–614 aa |
306–575 aa |
|
BLI |
1.2 nM |
|
|
328–533 aa |
5 nM |
|||
1–615 aa |
306–577 aa |
|
BLI |
13.7 nM |
|
|
319–591 aa |
34.6 nM |
Pseudo typed vesicular stomatitis virus expressing SARS-CoV-2 S (VSV-SARS-S2) expression system can be used efficiently infects cell lines, with Calu-3 human lung adenocarcinoma epithelial cell line, CaCo-2 human colorectal adenocarcinoma colon epithelial cell line and Vero African grey monkey kidney epithelial cell line being the most permissive (Hoffmann et al., 2020; Ou et al., 2020). It can be measured using a wide variety of assays targeting different biological phases of infection and altered cell membrane permeability and cell organelle signaling pathway. Other assay measured alteration in the levels of permissive cell lines all express ACE2 or hACE2-expressing 293T cell (e.g. pNUO1-hACE2, pFUSE-hIgG1-Fc2), as previously demonstrated by indirect immunofluorescence (IF) or by immunoblotting are associated with ELISA(W Tai et al., nature 2020). To prioritize the identified potential KEs for selection and to select a KE to serve as a case study, further in-silico data that ACE2 binds to SARS-CoV-2 S is necessary for virus entry. The above analysis outlined can be used evidence-based assessment of molecular evidence as a MIE.
Domain of Applicability
The KE is applicable to broad species/life stage/sex. The binding of ACE2 occure in the cells which express ACE2.
References
de Morais SDB, et al. Integrative Physiological Aspects of Brain RAS in Hypertension. Curr Hypertens Rep. 2018 Feb 26; 20(2):10.
Gallagher PE, et al. Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes. Am J Physiol Cell Physiol. 2006 Feb; 290(2):C420-6.
Gowrisankar YV, Clark MA. Angiotensin II regulation of angiotensin-converting enzymes in spontaneously hypertensive rat primary astrocyte cultures. J Neurochem. 2016 Jul; 138(1):74-85.
Hamming I et al. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol. 2004 Jun;203(2):631-7.
Jakhmola S, et al. SARS-CoV-2, an Underestimated Pathogen of the Nervous System. SN Compr Clin Med. 2020.
Lukiw WJ et al. SARS-CoV-2 Infectivity and Neurological Targets in the Brain. Cell Mol Neurobiol. 2020 Aug 25;1-8.
Matsushita T, et al. CSF angiotensin II and angiotensin-converting enzyme levels in anti-aquaporin-4 autoimmunity. J Neurol Sci. 2010 Aug 15; 295(1-2):41-5.
Murta et al. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders? ASN Neuro. 2020. PMID: 32878468
Shi A, et al. Isolation, purification and molecular mechanism of a peanut protein-derived ACE-inhibitory peptide. PLoS One. 2014; 9(10):e111188.
Xia, H. and Lazartigues, E. Angiotensin-Converting Enzyme 2: Central Regulator for Cardiovascular Function. Curr. Hypertens. 2010 Rep. 12 (3), 170– 175